. 2014 Jan 3;18(4):421–433. doi: 10.1016/j.bjid.2013.10.005

Table 1.

Number of study sites by country for key surveillance reports.

Country	Surveillance program and collection period
	SMART²⁷	SMART²⁸	SMART²⁹	SMART³⁰	TEST³¹	TEST³²	SENTRY³³	PAHO³⁴^,^a	PAHO³⁵^,^a
	2004	2005	2008	2008–2009	2004–2006	2004–2010	2008–2010	2006	2009
Argentina	3	2	2	2	9	12	2	59	72
Bolivia								19	30
Brazil	3	2	5	1	1	3	4
Chile	2		2	2	2	5	2
Colombia	1		3	2		14			147
Dominican Republic			1	1				14	14
Ecuador	1			1				21	22
El Salvador						1		33	33
Guatemala	1	1	1	1		4		6	5
Honduras						2		4	7
Mexico	2	2	3	4	1	15	2
Nicaragua						1		10	11
Panama	1	1	1	1		2		24	24
Paraguay								8	21
Peru		1	2					22	40
Puerto Rico	2	2		1
Venezuela	1		3	3		6		34	24

PAHO, Pan-American Health Organization; SMART, Study for Monitoring Antimicrobial Resistance Trends; TEST, Tigecycline Evaluation and Surveillance Trial.

Including only countries reporting data on Enterobacteriaceae in hospital settings.